Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
β Scribed by Gorgun, G.; Calabrese, E.; Soydan, E.; Hideshima, T.; Perrone, G.; Bandi, M.; Cirstea, D.; Santo, L.; Hu, Y.; Tai, Y.-T.; Nahar, S.; Mimura, N.; Fabre, C.; Raje, N.; Munshi, N.; Richardson, P.; Anderson, K. C.
- Book ID
- 111671439
- Publisher
- American Society of Hematology
- Year
- 2010
- Tongue
- English
- Weight
- 797 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0006-4971
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract MM is a Bβcell malignancy mainly characterized by monoclonal expansion of plasma cells in the BM, presence of paraprotein in serum and occurrence of osteolytic bone lesions. MMPs are a family of proteolytic enzymes that can contribute to cancer growth, invasion, angiogenesis, bone degra
Bone marrow natural killer (NK) cell activity was lopoiesis and possibly in vivo hematopoiesis (Hansson studied in patients with multiple myeloma. Bone marrow et a[., 1982; Lotzo\ra et al,, 1979). mononuclear cells from myeloma patients expressed consjde.b levels of cytotoxicity K562 i n a , , s~=,